Research Article: Noncontrast computed tomography factors predictive of extracorporeal shock wave lithotripsy outcomes in patients with pancreatic duct stones

Date Published: May 15, 2018

Publisher: Springer US

Author(s): Ri Liu, Weiwei Su, Jing Gong, Yu Zhang, Jianping Lu.

http://doi.org/10.1007/s00261-018-1639-4

Abstract

To assess the usefulness of factors unique to NCCT for the prediction of ESWL outcomes in patients with pancreatic duct stones.

We retrospectively evaluated 148 patients with multiple PDS who had undergone ESWL therapy. All patients received an examination for NCCT both before and after ESWL. The following parameters were measured and recorded: patient characteristics including sex and age; NCCT parameters including mean stone length, mean stone volumes before and after ESWL, mean value of CT attenuation, standard deviation of CT attenuation, variation coefficient of CT attenuation, skin-to-stone distance, and pancreatic duct diameter; ESWL outcome indexes including stone clearance rate calculated using the formula documentclass[12pt]{minimal}
usepackage{amsmath}
usepackage{wasysym}
usepackage{amsfonts}
usepackage{amssymb}
usepackage{amsbsy}
usepackage{mathrsfs}
usepackage{upgreek}
setlength{oddsidemargin}{-69pt}
begin{document}$$frac{V0 – V1}{V0} times 100%$$end{document}V0-V1V0×100%, and the number of ESWL sessions. All patients were divided into groups based on their SCR: A group (SCR ≥ 90%), B group (SCR between 50% and 90%), and C group (SCR < 50%). Analysis of variance was used among the three groups to evaluate the potential predictors of SCR, and a receiver-operating curve was established to determine the optimal cutoff value. ANOVA analysis revealed that MSD was the only significant predictor for SCR (p < 0.05), and ROC indicated an optimal cutoff value of +1000.45 HU, with a sensitivity up to 78.0% and specificity of 48.6%. Stones with MSD lower than +1000.45 HU had higher SCR (69.3%) than that of higher-density ones (59.6%). Pearson correlation analysis and histogram indicated a significant positive correlation between ESWL No. and MSL (r = 0.536), MSD (r = 0.250), SDSD (r = 0.247), and PDD (r = 0.227), all values being p < 0.01. MSD is the optimal predictor of ESWL efficacy, and PDS with lower MSD had a better clearance rate with fewer fragmentation sessions.

Partial Text

Chronic pancreatitis (CP) is an intractable and progressive inflammatory disease often complicated by pancreatic duct stones (PDS). These stones are the primary contributor to the abdominal pain of CP patients because they cause parenchymal or functional damage to the pancreas. ESWL is currently the most common nonsurgical intervention for PDS patients, especially for those with multiple, large stones that cannot be completely removed with endoscopic retrograde cholangiopancreatography (ERCP). The success rate of ESWL alone can reach up to 100% according to some reports [18, 19].

By studying a sufficiently large number of patients with pancreatic duct stones who had undergone ESWL therapy, we were able to make a comprehensive analysis of potential predictors of ESWL outcomes and fully demonstrated the important value of quantitative NCCT in the assessment of need for and efficacy of ESWL. Nevertheless, more extensive studies including patient physical characteristics, previous clinical therapy, and follow-up data, which may be suggestive of a cure for patients suffering from chronic pancreatitis with PDS, are desired.

 

Source:

http://doi.org/10.1007/s00261-018-1639-4

 

Leave a Reply

Your email address will not be published.